Insider · CIK 0001337801
Randal W. Scott
Files at BBIO (BridgeBio Pharma, Inc.). First filing Nov 19, 2025, latest May 19, 2026.
Randal W. Scott files SEC Form 4 as director at BBIO (BridgeBio Pharma, Inc.). Since Nov 19, 2025, Randal W. Scott has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.1M, the latest filed on May 19, 2026.
A track record needs three past buys with six months of prices behind them; Randal W. Scott has 0, so none is measured yet.
The newest scored trade: sold $671k of BBIO on May 15, 2026, filed May 19, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $2.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | BridgeBio Pharma, Inc. | $671k 10,000 shares | -46% | +105% from low-17% from high | |
| 27Weak | BridgeBio Pharma, Inc. | $755k 10,000 shares | -46% | +152% from low-5% from high | |
| 25Weak | BridgeBio Pharma, Inc. | $666k 10,000 shares | -46% | +199% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | 20,000 0.01% of outstanding | $1.5M | Feb 17, 2026 | none |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | 10,000 0.01% of outstanding | $664k | Nov 17, 2025 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $16.75 | $168k | 21,589 | May 19, 2026 |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -6,200 | $66.69 | $413k | 15,389 | May 19, 2026 |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -2,088 | $67.53 | $141k | 13,301 | May 19, 2026 |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -1,512 | $68.23 | $103k | 11,789 | May 19, 2026 |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $69.12 | $14k | 11,589 | May 19, 2026 |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 21,501 | May 19, 2026 |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $16.75 | $168k | 21,589 | Feb 18, 2026 |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -1,900 | $74.34 | $141k | 19,689 | Feb 18, 2026 |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -4,793 | $75.57 | $362k | 14,896 | Feb 18, 2026 |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -3,307 | $75.93 | $251k | 11,589 | Feb 18, 2026 |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 31,501 | Feb 18, 2026 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $16.75 | $168k | 21,589 | Nov 19, 2025 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -3,801 | $66.25 | $252k | 17,788 | Nov 19, 2025 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -6,199 | $66.89 | $415k | 11,589 | Nov 19, 2025 |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 41,501 | Nov 19, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 11,589 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
Questions about Randal W. Scott
Answered from the filings on this page, as of the latest one.
Is Randal W. Scott buying or selling?
In the last 12 months Randal W. Scott reported 0 open-market buys worth $0 and 3 open-market sells worth $2.1M on SEC Form 4; the latest was sold $671k of BBIO on May 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Randal W. Scott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randal W. Scott has 0.
Where does Randal W. Scott file Form 4?
Randal W. Scott has filed Form 4 at BBIO (BridgeBio Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.